Cargando…

PDRG1 at the interface between intermediary metabolism and oncogenesis

PDRG1 is a small oncogenic protein of 133 residues. In normal human tissues, the p53 and DNA damage-regulated gene 1 (PDRG1) gene exhibits maximal expression in the testis and minimal levels in the liver. Increased expression has been detected in several tumor cells and in response to genotoxic stre...

Descripción completa

Detalles Bibliográficos
Autor principal: Pajares, María Ángeles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714802/
https://www.ncbi.nlm.nih.gov/pubmed/29225734
http://dx.doi.org/10.4331/wjbc.v8.i4.175
_version_ 1783283634603556864
author Pajares, María Ángeles
author_facet Pajares, María Ángeles
author_sort Pajares, María Ángeles
collection PubMed
description PDRG1 is a small oncogenic protein of 133 residues. In normal human tissues, the p53 and DNA damage-regulated gene 1 (PDRG1) gene exhibits maximal expression in the testis and minimal levels in the liver. Increased expression has been detected in several tumor cells and in response to genotoxic stress. High-throughput studies identified the PDRG1 protein in a variety of macromolecular complexes involved in processes that are altered in cancer cells. For example, this oncogene has been found as part of the RNA polymerase II complex, the splicing machinery and nutrient sensing machinery, although its role in these complexes remains unclear. More recently, the PDRG1 protein was found as an interaction target for the catalytic subunits of methionine adenosyltransferases. These enzymes synthesize S-adenosylmethionine, the methyl donor for, among others, epigenetic methylations that occur on the DNA and histones. In fact, downregulation of S-adenosylmethionine synthesis is the first functional effect directly ascribed to PDRG1. The existence of global DNA hypomethylation, together with increased PDRG1 expression, in many tumor cells highlights the importance of this interaction as one of the putative underlying causes for cell transformation. Here, we will review the accumulated knowledge on this oncogene, emphasizing the numerous aspects that remain to be explored.
format Online
Article
Text
id pubmed-5714802
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-57148022017-12-08 PDRG1 at the interface between intermediary metabolism and oncogenesis Pajares, María Ángeles World J Biol Chem Minireviews PDRG1 is a small oncogenic protein of 133 residues. In normal human tissues, the p53 and DNA damage-regulated gene 1 (PDRG1) gene exhibits maximal expression in the testis and minimal levels in the liver. Increased expression has been detected in several tumor cells and in response to genotoxic stress. High-throughput studies identified the PDRG1 protein in a variety of macromolecular complexes involved in processes that are altered in cancer cells. For example, this oncogene has been found as part of the RNA polymerase II complex, the splicing machinery and nutrient sensing machinery, although its role in these complexes remains unclear. More recently, the PDRG1 protein was found as an interaction target for the catalytic subunits of methionine adenosyltransferases. These enzymes synthesize S-adenosylmethionine, the methyl donor for, among others, epigenetic methylations that occur on the DNA and histones. In fact, downregulation of S-adenosylmethionine synthesis is the first functional effect directly ascribed to PDRG1. The existence of global DNA hypomethylation, together with increased PDRG1 expression, in many tumor cells highlights the importance of this interaction as one of the putative underlying causes for cell transformation. Here, we will review the accumulated knowledge on this oncogene, emphasizing the numerous aspects that remain to be explored. Baishideng Publishing Group Inc 2017-11-26 2017-11-26 /pmc/articles/PMC5714802/ /pubmed/29225734 http://dx.doi.org/10.4331/wjbc.v8.i4.175 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Minireviews
Pajares, María Ángeles
PDRG1 at the interface between intermediary metabolism and oncogenesis
title PDRG1 at the interface between intermediary metabolism and oncogenesis
title_full PDRG1 at the interface between intermediary metabolism and oncogenesis
title_fullStr PDRG1 at the interface between intermediary metabolism and oncogenesis
title_full_unstemmed PDRG1 at the interface between intermediary metabolism and oncogenesis
title_short PDRG1 at the interface between intermediary metabolism and oncogenesis
title_sort pdrg1 at the interface between intermediary metabolism and oncogenesis
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714802/
https://www.ncbi.nlm.nih.gov/pubmed/29225734
http://dx.doi.org/10.4331/wjbc.v8.i4.175
work_keys_str_mv AT pajaresmariaangeles pdrg1attheinterfacebetweenintermediarymetabolismandoncogenesis